Jie-hong Wu
Union Hospital
Wuhan, 430022, China
Wuhan, 430022, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Engineered ETS1-Nanoconjugate Restores Immune Homeostasis through Dual Immune-Vascular Modulation in Relapsing and Progressive Multiple Sclerosis.
Journal: Advanced healthcare materials
Published: November 07, 2025
Microvascular endothelial metabolic dysfunction drives cerebral edema through bioenergetic failure after ischemia-reperfusion.
Journal: Theranostics
Published: October 23, 2025
TTK Inhibition Alleviates Postinjury Neointimal Formation and Atherosclerosis.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: August 06, 2024
Recent advances of self-assembled nanoparticles in the diagnosis and treatment of atherosclerosis.
Journal: Theranostics
Published: July 02, 2024
Endogenous Retroviruses Unveiled: A Comprehensive Review of Inflammatory Signaling/Senescence-Related Pathways and Therapeutic Strategies.
Journal: Aging and disease
Published: February 02, 2024
Lipid accumulation and novel insight into vascular smooth muscle cells in atherosclerosis.
Journal: Journal of molecular medicine (Berlin, Germany)
Published: November 01, 2020
Inhibition of Sema4D/PlexinB1 signaling alleviates vascular dysfunction in diabetic retinopathy.
Journal: EMBO molecular medicine
Published: December 03, 2018
Semaphorin-3A protects against neointimal hyperplasia after vascular injury.
Journal: EBioMedicine
Published: September 19, 2018
Sema3E/PlexinD1 inhibition is a therapeutic strategy for improving cerebral perfusion and restoring functional loss after stroke in aged rats.
Journal: Neurobiology of aging
Published: November 04, 2017
Semaphorin-3E attenuates neointimal formation via suppressing VSMCs migration and proliferation.
Journal: Cardiovascular research
Published: January 13, 2017
Showing 1-11 of 11
Last Updated: 09/26/2026